Abstract
Results of epidemiological studies of recent years indicate an increase in the frequency of purulent-septic lesions of soft tissues in general, including Fournier's gangrene. It is believed that the current situation is associated with an increase in the number of immunodeficient patients in the population, who make up the main contingent of patients with Fournier's gangrene. In addition, despite modern antibacterial agents, mortality in GF does not decrease and remains very high, reaching 80%, according to individual studies. The purpose of our research is to develop diagnostic criteria and improve a set of therapeutic measures in the treatment of patients with Fournier's gangrene.